HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,645-1,656 of 1,811
Drug study icon
CompletedNCT00266552

Effectiveness of risperidone in ADHD

Official study title

The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder and Other Disruptive Behavior Disorders In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 5–12
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium
Drug study icon
CompletedNCT01199315

Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

Official study title

A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 in Young and Elderly Healthy Japanese Volunteers After Oral Single and Repeated Doses

This study has finished and is no longer accepting participants.

In Fukuoka
ADHDMedication studyAges 20–80
Countries
Japan
Sponsor
AstraZeneca
Drug study icon
CompletedNCT00368849

Atomoxetine and Huntington's Disease

Official study title

Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study

This study has finished and is no longer accepting participants.

In Iowa City
ADHDMedication studyAges 18–65
Countries
United States
Sponsor
University of Iowa
Other study type icon
CompletedNCT01263756

Autism Spectrum Disorders (ASD) Driving Study

Official study title

A Study of the Driving Performance of Individuals With Autism Spectrum Disorders

This study has finished and is no longer accepting participants.

In Cambridge
ADHDObservational studyAges 16–50
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Behavioral study icon
CompletedNCT03490110

Brain Markers of Improvements in Cognitive Functioning

Official study title

EEG Markers of Training-Induced Improvements in Cognitive Functioning

This study has finished and is no longer accepting participants.

In Sacramento
ADHDBehavioural studyAges 21–55
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.